Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karsten Midtvedt

Showing results (141-150 of 153) with videos related to

Pageof 16
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|June 14, 2005
Use of Neoral C monitoring: a European consensusBjorn Nashan, Andreas Bock, Jean-Louis Bosmans, et al.
Diabetologia|August 23, 2014
In patients with type 1 diabetes simultaneous pancreas and kidney transplantation preserves long-term kidney graft ultrastructure and function better than transplantation of kidney aloneJørn P Lindahl, Finn P Reinholt, Ivar A Eide, et al.
Frontiers in Immunology|July 15, 2024
Cellular immunity against cytomegalovirus and risk of infection after kidney transplantationKjersti B Blom, Grete B Kro, Karsten Midtvedt, et al.
Plos One|December 16, 2020
Exploring the potential effect of paricalcitol on markers of inflammation in de novo renal transplant recipientsHege Kampen Pihlstrøm, Thor Ueland, Annika E Michelsen, et al.
Transplantation|May 22, 2023
Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic ManagementKjersti B Blom, Grete K Birkeland, Karsten Midtvedt, et al.
Kidney International|November 29, 2013
Long-term risks for kidney donorsGeir Mjøen, Stein Hallan, Anders Hartmann, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 2, 2017
Tacrolimus and mycophenolate regimen and subclinical tubulo-interstitial inflammation in low immunological risk renal transplantsIrina B Torres, Anna V Reisaeter, Francesc Moreso, et al.
Ebiomedicine|October 16, 2023
Hybrid and SARS-CoV-2-vaccine immunity in kidney transplant recipientsHassen Kared, Amin Alirezaylavasani, Katrine Persgård Lund, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 26, 2022
Prolonged-Release Once-Daily Formulation of Tacrolimus Versus Standard-of-Care Tacrolimus in <i>de novo</i> Kidney Transplant Patients Across EuropeKlemens Budde, Lionel Rostaing, Umberto Maggiore, et al.
Transplantation|August 4, 2012
Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trialBernhard K Krämer, Marian Klinger, Štefan Vítko, et al.
Pageof 16

Showing results (141-150 of 153) with videos related to

Sort By:
Pageof 16
Transplant International : Official Journal of the European Society for Organ Transplantation|June 14, 2005
Use of Neoral C monitoring: a European consensusBjorn Nashan, Andreas Bock, Jean-Louis Bosmans, et al.
Diabetologia|August 23, 2014
In patients with type 1 diabetes simultaneous pancreas and kidney transplantation preserves long-term kidney graft ultrastructure and function better than transplantation of kidney aloneJørn P Lindahl, Finn P Reinholt, Ivar A Eide, et al.
Frontiers in Immunology|July 15, 2024
Cellular immunity against cytomegalovirus and risk of infection after kidney transplantationKjersti B Blom, Grete B Kro, Karsten Midtvedt, et al.
Plos One|December 16, 2020
Exploring the potential effect of paricalcitol on markers of inflammation in de novo renal transplant recipientsHege Kampen Pihlstrøm, Thor Ueland, Annika E Michelsen, et al.
Transplantation|May 22, 2023
Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic ManagementKjersti B Blom, Grete K Birkeland, Karsten Midtvedt, et al.
Kidney International|November 29, 2013
Long-term risks for kidney donorsGeir Mjøen, Stein Hallan, Anders Hartmann, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 2, 2017
Tacrolimus and mycophenolate regimen and subclinical tubulo-interstitial inflammation in low immunological risk renal transplantsIrina B Torres, Anna V Reisaeter, Francesc Moreso, et al.
Ebiomedicine|October 16, 2023
Hybrid and SARS-CoV-2-vaccine immunity in kidney transplant recipientsHassen Kared, Amin Alirezaylavasani, Katrine Persgård Lund, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 26, 2022
Prolonged-Release Once-Daily Formulation of Tacrolimus Versus Standard-of-Care Tacrolimus in <i>de novo</i> Kidney Transplant Patients Across EuropeKlemens Budde, Lionel Rostaing, Umberto Maggiore, et al.
Transplantation|August 4, 2012
Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trialBernhard K Krämer, Marian Klinger, Štefan Vítko, et al.
Pageof 16